NEW YORK, Oct. 18 – Roche Diagnostics and Quest Diagnostics have penned a deal to jointly develop gene-based tests to predict a person’s likelihood of developing particular diseases and to evaluate the best course of treatment.

The companies said they would work together to commercialize gene-based markers to determine a person’s risk for stroke or asthma.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.